康惠制药(603139.SH)控股股东变更为悦合智创

Group 1 - The core point of the article is that Kanghui Pharmaceutical has completed adjustments related to corporate governance as outlined in the supplementary agreement of the share transfer agreement [1] - Kanghui Holdings voluntarily relinquishes its voting rights corresponding to 10% of the shares held in Kanghui Pharmaceutical, resulting in a change of the controlling shareholder to Yuehe Zhichuang [1] - The actual controllers of the company have changed to Li Hongming and Wang Xuefang, a couple [1]